-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/2XRG8Dz2EegVWYUrRThgmD
October 01, 2015 - None of the drugs were
associated with major cardiovascular adverse events. … Nicotine replace-
ment therapy was associated with an increased risk for
any cardiovascular event, driven … predominantly by mi-
nor cardiovascular events, such as tachycardia and ar-
rhythmia (49). … AE = adverse event; CV = cardiovascular; ENDS = electronic nicotine delivery system; NA = not applicable … Risk of cardiovascular serious adverse
events associated with varenicline use for tobacco cessation:
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2007_MaskedStats_Core_Weighted.PDF
January 01, 2007 - 106: CORONARY BYPASS W PTCA 7810 0.02
108: OTHER CARDIOTHORACIC PROCEDURES 26265 0.07
110: MAJOR CARDIOVASCULAR … PROCEDURES W CC 101563 0.26
111: MAJOR CARDIOVASCULAR PROCEDURES W/O CC 22727 0.06
113: AMPUTATION … : PERCUTANEOUS CARDIOVASC PROC W NON-DRUG-ELUTING STENT W/O MAJ CV DX 79769 0.20
557: PERCUTANEOUS CARDIOVASCULAR … PROC W DRUG-ELUTING STENT W MAJOR CV DX 191807 0.49
558: PERCUTANEOUS CARDIOVASCULAR PROC W DRUG-ELUTING … procedures 23199 0.06
63: Other non-OR therapeutic cardiovascular procedures 88987 0.23
64: Bone marrow
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2008_MaskedStats_Core_Weighted.PDF
January 01, 2008 - : CORONARY BYPASS W PTCA 7,839 0.02%
108: OTHER CARDIOTHORACIC PROCEDURES 29,750 0.07%
110: MAJOR CARDIOVASCULAR … PROCEDURES W CC 109,777 0.28%
111: MAJOR CARDIOVASCULAR PROCEDURES W/O CC 27,803 0.07%
113: AMPUTATION … 59,137 0.15%
554: OTHER VASCULAR PROCEDURES W CC W/O MAJOR CV DX 121,251 0.30%
555: PERCUTANEOUS CARDIOVASCULAR … PROC W DRUG-ELUTING STENT W MAJOR CV DX 202,647 0.51%
558: PERCUTANEOUS CARDIOVASCULAR PROC W DRUG-ELUTING … procedures 23,603 0.06%
63: Other non-OR therapeutic cardiovascular procedures 84,496 0.21%
64: Bone
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2006_MaskedStats_Core_Weighted.PDF
January 01, 2006 - 106: CORONARY BYPASS W PTCA 8306 0.02
108: OTHER CARDIOTHORACIC PROCEDURES 32275 0.08
110: MAJOR CARDIOVASCULAR … PROCEDURES W CC 106029 0.27
111: MAJOR CARDIOVASCULAR PROCEDURES W/O CC 22872 0.06
113: AMPUTATION … : PERCUTANEOUS CARDIOVASC PROC W NON-DRUG-ELUTING STENT W/O MAJ CV DX 42991 0.11
557: PERCUTANEOUS CARDIOVASCULAR … PROC W DRUG-ELUTING STENT W MAJOR CV DX 301228 0.76
558: PERCUTANEOUS CARDIOVASCULAR PROC W DRUG-ELUTING … procedures 26660 0.07
63: Other non-O.R. therapeutic cardiovascular procedures 110078 0.28
64: Bone
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2012_MaskedStats_Core_Weighted.PDF
January 01, 2012 - : CORONARY BYPASS W PTCA 5,975 0.02%
108: OTHER CARDIOTHORACIC PROCEDURES 27,415 0.08%
110: MAJOR CARDIOVASCULAR … PROCEDURES W CC 101,425 0.28%
111: MAJOR CARDIOVASCULAR PROCEDURES W/O CC 22,495 0.06%
113: AMPUTATION … 51,965 0.14%
554: OTHER VASCULAR PROCEDURES W CC W/O MAJOR CV DX 105,075 0.29%
555: PERCUTANEOUS CARDIOVASCULAR … PROC W DRUG-ELUTING STENT W MAJOR CV DX 232,830 0.64%
558: PERCUTANEOUS CARDIOVASCULAR PROC W DRUG-ELUTING … procedures 20,820 0.06%
63: Other non-OR therapeutic cardiovascular procedures 99,015 0.27%
64: Bone
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2012_MaskedStats_Core_Weighted.PDF
January 01, 2012 - .**%
108: OTHER CARDIOTHORACIC PROCEDURES 11,249 0.17%
110: MAJOR CARDIOVASCULAR PROCEDURES W CC 4,704 … 16, 2014 21
Weighted Frequency Distribution for DRG24
DRG24 Frequency
Percent
of Total
111: MAJOR CARDIOVASCULAR … CV DX 450 0.01%
554: OTHER VASCULAR PROCEDURES W CC W/O MAJOR CV DX 1,145 0.02%
555: PERCUTANEOUS CARDIOVASCULAR … PROC W DRUG-ELUTING STENT
W MAJOR CV DX
<= 50 *.**%
558: PERCUTANEOUS CARDIOVASCULAR PROC W DRUG-ELUTING … procedures 796 0.01%
63: Other non-OR therapeutic cardiovascular procedures 1,242 0.02%
64: Bone marrow
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/PublicSummaryStats_KID_2006_Core.PDF
January 01, 2006 - June 10, 2008 17
Frequency Distribution for DRG24
DRG24 Frequency
Percent
of
Total
110: MAJOR CARDIOVASCULAR … PROCEDURES W CC 3269 0.10
111: MAJOR CARDIOVASCULAR PROCEDURES W/O CC 976 0.03
113: AMPUTATION FOR … 556: PERCUTANEOUS CARDIOVASC PROC W NON-DRUG-ELUTING STENT W/O MAJ
CV DX
28 0.00
557: PERCUTANEOUS CARDIOVASCULAR … PROC W DRUG-ELUTING STENT W MAJOR
CV DX
27 0.00
558: PERCUTANEOUS CARDIOVASCULAR PROC W DRUG-ELUTING … procedures 501 0.02
63: Other non-O.R. therapeutic cardiovascular procedures 1020 0.03
64: Bone marrow
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2012_MaskedStats_Core.PDF
January 01, 2012 - .**%
108: OTHER CARDIOTHORACIC PROCEDURES 7,842 0.25%
110: MAJOR CARDIOVASCULAR PROCEDURES W CC 3,293 … 556: PERCUTANEOUS CARDIOVASC PROC W NON-DRUG-ELUTING STENT
W/O MAJ CV DX
25 0.00%
557: PERCUTANEOUS CARDIOVASCULAR … PROC W DRUG-ELUTING STENT
W MAJOR CV DX
23 0.00%
558: PERCUTANEOUS CARDIOVASCULAR PROC W DRUG-ELUTING … 0.00%
61: Other OR procedures on vessels other than head and neck 7,934 0.25%
62: Other diagnostic cardiovascular … procedures 564 0.02%
63: Other non-OR therapeutic cardiovascular procedures 883 0.03%
64: Bone marrow
-
www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/building-capacity/en-bsc-interim-report-2.pdf
July 01, 2024 - EvidenceNOW BSC: Interim Evaluation Report II June 2023 ▌v
Acronyms
Acronym Meaning
ACC Alabama Cardiovascular … Education
CMS Centers for Medicare & Medicaid Services
CPC+ Comprehensive Primary Care Plus
CVD Cardiovascular … 2023 ▌ii
Cooperative’s Commitment and Investment in Retention
Respondents from both the Alabama Cardiovascular … Health in States with High Prevalence of Preventable CVD
(cardiovascular disease) Events; AHRQ calls … Alabama Cardiovascular Cooperative (ACC)
ACC respondents shared that the most effective recruitment
-
digital.ahrq.gov/sites/default/files/docs/publication/r01hs015123-cebul-final-report-2008.pdf
January 01, 2008 - in the United States and the most common cause of adult blindness,
amputations, kidney failure and cardiovascular … Cardiovascular disease (CVD)
is the cause of death in about 65% of diabetics 2, and is accelerated by … Effects of ramipril on cardiovascular
and microvascular outcomes in people with diabetes
mellitus: … Effects of
losartan on renal and cardiovascular outcomes in
patients with type 2 diabetes and nephropathy
-
digital.ahrq.gov/sites/default/files/docs/page/2016-ahrq-hit-annual-report.pdf
January 01, 2016 - Health IT Division funds projects that study a variety of medical and health
conditions, including cardiovascular … Medical Conditions Total
Chronic Conditions 19
Mental/Behavioral Health 9
Diabetes Mellitus 7
Cardiovascular … Knowledge &
Prevent Readmission RFA-HS-14-010
Chrischilles, Elizabeth Design and Testing of a Mobile Cardiovascular … Patient-Centered mHealth Tool to
Enhance Post-Cystectomy Care PA-13-039
Wasson, Lauren Improving Diagnosis of Cardiovascular
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-treatment-ssri_executive.pdf
April 01, 2012 - obesity,5 smoking,6
and sedentary lifestyles.7 MDD may be
associated with immune dysfunction8-11
and cardiovascular … The integration of cardiovascular behavioral
medicine and psychoneuroimmunology: New developments
based … Depression
and cardiovascular sequelae in postmenopausal women. … Assessment and
treatment of depression in patients with cardiovascular disease:
National Heart, Lung
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-228-fullreport.pdf
February 01, 2018 - example, a measure
addressing childhood obesity may have implications for the subsequent development
of cardiovascular … Severe sepsis includes sepsis plus one of the following clinical states: cardiovascular organ
dysfunction … Septic shock is defined as sepsis and cardiovascular dysfunction (Goldstein, et al., 2005;
Rivers, … Shock occurs when the cardiovascular
system is unable to provide energy resources (oxygen and glucose
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-229-opioid-treatments-chronic-pain-evidence-summary.pdf
April 01, 2020 - gastrointestinal-
related harms, falls, fractures, motor vehicle
accidents, endocrinological harms, infections,
cardiovascular … gastrointestinal-related harms, falls, fractures,
motor vehicle accidents, endocrinological
harms, infections, cardiovascular … gastrointestinal-
related harms, falls, fractures, motor vehicle
accidents, endocrinological harms, infections,
cardiovascular … between use of prescription opioids and risk of
addiction,22 overdose,22 fractures,23-25 falls24,26 and
cardiovascular
-
effectivehealthcare.ahrq.gov/sites/default/files/s131.pdf
October 01, 2007 - 411.xx, 413.xx or use of nitrates
Atrial fibrillation 427.31
Cancer 140.xx–172.xx, 174.xx–239.xx
Cardiovascular … (categorical)
Cardiovascular system symptoms 785.xx
Cataract 366.xx
Chest pain 786.5x
Chronic obstructive … , 33521, 33522, 33523, 33530, 33533, 33534, 33535, 33536, 33545 OR DRG 106, 107,
112
Visits with a cardiovascular … (categorical)
Use of medications
Corticosteroids
Cardiovascular
Estrogen
Loop diuretics
Nonsteroidal
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/ovarian-cancer-screening
February 13, 2018 - these operations (15/488), including infection, injury to hollow viscus, anesthetic complications, and cardiovascular … Major complications occurred in 15.1% of these operations, including infection, direct surgical harms, cardiovascular … time of benign hysterectomy. 49 Removal of the ovaries, in the absence medical indication, may affect cardiovascular … Includes infection (89), direct surgical harms (63), cardiovascular or pulmonary events (31), other (
-
hcup-us.ahrq.gov/reports/methods/2008_04.pdf
January 01, 2008 - categories needing an upward adjustment
of CCR were in labor and delivery, newborns, nervous system, cardiovascular … Categories needing a downward
adjustment included surgical services such as cardiovascular procedures … categories needing an
upward adjustment of CCR were in labor and delivery, newborns, nervous system,
cardiovascular … Categories needing a downward adjustment included surgical services such as
cardiovascular procedures
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/does-the-use-of-cytochrome-p450-2c19-cyp2c19-testing-to-predict-response-to-clopidogrel-in-people-1-with-acute-coronary-syndrome-2-who-have-suffered-other-cardiovascular-disease-related-events-eg-ischemic-stroke-symptomatic-
-
hcup-us.ahrq.gov/reports/natstats/commdx/table1j.htm
February 11, 2011 - Other non-OR therapeutic cardiovascular procedures [63] 51,579 100.00 0.15
-
hcup-us.ahrq.gov/reports/natstats/commdx/table2e.htm
February 11, 2011 - Other diagnostic cardiovascular procedures [62] 4,907 2.59 0.01